Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Novartis    NOVN   CH0012005267

NOVARTIS

(NOVN)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Sector news Pharmaceuticals - NEC
02:48aJ&J Recalls Baby Powder For Asbestos -- WSJ
DJ
10/18More Money Demanded in Opioid Settlement Talks -- Update
DJ
10/18More Money Demanded in Opioid Settlement Talks
DJ
10/18JOHNSON & JOHNSON : J&J Recalls Baby Powder on Asbestos Concern -- 2nd Update
DJ
10/18Sanofi pulls Zantac from U.S. and Canada after carcinogen found
RE
10/18Johnson & Johnson Down Over 5%, on Pace for Largest Percent Decrease Since De..
DJ
10/18J&J Recalls Baby Powder on Asbestos Concern -- Update
DJ
10/18OPIOID LITIGATION TALKS CAN 'GET A L : lawyer
RE
10/18SANOFI : Recalls Over-the-Counter Zantac in U.S. and Canada
DJ
10/18GRAPHIC - TAKE FIVE : Super Saturday, Super Mario
RE
10/18ALLERGAN : Form 8.3 -
DJ
10/18JOHNSON & JOHNSON : J&J Recalls One Baby Powder Lot After Test Shows Subordinate..
DJ
10/18ABBVIE : Gets CHMP Positive Opinion for Rinvoq in Rheumatoid Arthritis
DJ
10/18JOHNSON & JOHNSON : J&J's Janssen Gets CHMP Positive Option for Spravato
DJ
10/18JOHNSON & JOHNSON : Genmab, Janssen Get CHMP Positive Option for Expanded Darzal..
DJ
10/18MERCK AND : Gets Positive EU CHMP Opinion for Two New Regimens of Keytruda
DJ
10/18MERCK AND : Gets CHMP Positive Opinion for V920 Ebola Zaire Virus Vaccine
DJ
10/18AMGEN : UCB Get CHMP Positive Opinion for Evenity
DJ
10/18Bellwether Opioid Deal Talks Ramp Up -- WSJ
DJ
10/17JOHNSON & JOHNSON : Janssen Presents New Long-term Tremfya Data
DJ
10/17Talks to Settle Opioid Lawsuits Intensify
DJ
10/17JOHNSON & JOHNSON : to Pay $117 Million Over Surgical Device Marketing
DJ
10/17As 'Cannabis 2.0' kicks off in Canada, industry strangled by limited retail o..
RE
10/17TEVA PHARMACEUTICAL INDUSTRIES : UK arm recalls some batches of Ranitidine - Med..
RE
10/17ALLERGAN : Form 8.3 -
DJ
10/17Teva to donate over $15 billion worth of drugs in opioid settlement - source
RE
10/17JOHNSON & JOHNSON : J&J Seeks $4 Billion Opioid Settlement
DJ
10/16DRUG FIRMS OFFER TO SETTLE U.S. OPIO : sources
RE
10/16JOHNSON & JOHNSON : J&J Offers $4 Billion Opioid Litigation Settlement
DJ
10/16Johnson & Johnson Shares Rise
DJ
10/16GLOBAL MARKETS LIVE : Roche, Bank of America, Alphabet, MGM…
10/16ALLERGAN : Form 8.3 -
DJ
10/16ACHILLION PHARMACEUTICALS : Shares Up 84% on Buyout Deal
DJ
10/16ELI LILLY AND : Phase 3 Pegilodecakin Study Misses Main Endpoint in Pancreatic C..
DJ
10/16ALEXION PHARMACEUTICALS : Buys Achillion Pharma for $930 Million
DJ
10/16EUROPE MARKETS: European Stocks Slip On Pessimism Over Brexit Deal And U.S.-C..
DJ
10/16Factbox - How are businesses preparing for a 'no-deal Brexit'?
RE
10/16ATOS : Signs Contract With Bayer for Digital Workplace Services
DJ
10/16Drug Firms In Talks To Settle Lawsuits -- WSJ
DJ
10/16ROCHE : Says Outlook Is Improving as Revenue Grows
DJ
10/15New Gilead Sciences CFO Expected to Pursue More Deals to Expand Portfolio
DJ
10/15Drug Distributors in Talks to Settle Opioid Litigation for $18 Billion -- 3rd..
DJ
10/15Drug Distributors in Talks to Settle Opioid Litigation for $18 Billion -- Upd..
DJ
10/15Drug Distributors in Talks to Settle Opioid Litigation for $18 Billion
DJ
10/15JOHNSON & JOHNSON : Raises Outlook, Beats Profit Estimates -- 2nd Update
DJ
10/15Drug Distributors in Talks to Settle Opioid Litigation for $18 Billion -- 2nd..
DJ
10/15ELI LILLY AND : Correction to Eli Lilly Promoting Women Article on Oct. 15 -- Jo..
DJ
10/15LONDON MARKETS: Pound Surges On Report Of Possible Draft Brexit Deal
DJ
10/15MERCK : Progyny Inc. Sets IPO at 10 Million Shares; Sees Pricing at $14-$16 Each
DJ
10/15JOHNSON & JOHNSON : Raises Outlook, Beats Profit Estimates -- Update
DJ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on NOVARTIS